(Q34427580)

2 August 2017

1 reference

title

CD4 T cells in tumor immunity (English)

1 reference

2 August 2017

Mara Gerloni

1

1 reference

2 August 2017

Maurizio Zanetti

series ordinal

2

1 reference

2 August 2017

publication date

15 March 2005

1 reference

Seminars in Immunopathology

2 August 2017

published in

1 reference

2 August 2017

volume

27

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

37-48

1 reference

https://scigraph.springernature.com/pub.10.1007/s00281-004-0193-z

2 August 2017

exact match

0 references

cites work

Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1

1 reference

12 December 2020

Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes

1 reference

12 December 2020

Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.

1 reference

12 December 2020

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

1 reference

12 December 2020

Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines

1 reference

12 December 2020

Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

1 reference

12 December 2020

Role of CD8+ T cells in murine experimental allergic encephalomyelitis

1 reference

12 December 2020

Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules

1 reference

12 December 2020

Interleukin 7 induces CD4+ T cell-dependent tumor rejection

1 reference

12 December 2020

Immune surveillance against a solid tumor fails because of immunological ignorance

1 reference

12 December 2020

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

12 December 2020

Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.

1 reference

12 December 2020

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

1 reference

12 December 2020

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

1 reference

12 December 2020

CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase

1 reference

12 December 2020

Type 1 and type 2: a fundamental dichotomy for all T-cell subsets

1 reference

12 December 2020

Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells

1 reference

12 December 2020

Control of immune responses by naturally arising CD4+ regulatory T cells that express toll-like receptors

1 reference

12 December 2020

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

12 December 2020

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

12 December 2020

The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity

1 reference

12 December 2020

A Theory of Self-Nonself Discrimination: Paralysis and induction involve the recognition of one and two determinants on an antigen, respectively

1 reference

12 December 2020

Dominance and crypticity of T cell antigenic determinants

1 reference

12 December 2020

CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice

1 reference

12 December 2020

PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia.

1 reference

12 December 2020

MHC ligands and peptide motifs: first listing

1 reference

12 December 2020

Activation of CD4 T cells by somatic transgenesis induces generalized immunity of uncommitted T cells and immunologic memory.

1 reference

12 December 2020

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

12 December 2020

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes

1 reference

12 December 2020

CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens

1 reference

12 December 2020

Cytotoxic T lymphocyte activation by cross-priming

1 reference

12 December 2020

P53(110-124)-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cells

1 reference

12 December 2020

Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection

1 reference

12 December 2020

Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells

1 reference

12 December 2020

Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells

1 reference

12 December 2020

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

1 reference

12 December 2020

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

1 reference

12 December 2020

CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope.

1 reference

12 December 2020

Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells

1 reference

12 December 2020

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

1 reference

12 December 2020

Role of T cell help and endoplasmic reticulum targeting in protective CTL response against influenza virus

1 reference

12 December 2020

Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors

1 reference

12 December 2020

Functional cooperation between T helper cell determinants

1 reference

12 December 2020

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

12 December 2020

A Disquisition on Suppressor T Cells

1 reference

12 December 2020

Control of T-cell activation by CD4+ CD25+ suppressor T cells

1 reference

12 December 2020

Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient

1 reference

12 December 2020

Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity

1 reference

12 December 2020

NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells

1 reference

12 December 2020

Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells

1 reference

12 December 2020

Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon

1 reference

12 December 2020

Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development

1 reference

12 December 2020

Identification of a naturally processed HLA-DR-restricted T-helper epitope in Epstein-Barr virus nuclear antigen type 1.

1 reference

12 December 2020

Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells.

1 reference

12 December 2020

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

1 reference

12 December 2020

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

1 reference

12 December 2020

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

1 reference

12 December 2020

A simple method to cure established tumors by inflammatory killing of normal cells

1 reference

12 December 2020

Type 1 T regulatory cells.

1 reference

12 December 2020

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production

1 reference

12 December 2020

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

1 reference

12 December 2020

Human telomerase reverse transcriptase-specific T-helper responses induced by promiscuous major histocompatibility complex class II-restricted epitopes

1 reference

12 December 2020

Immunotherapy: past, present and future

1 reference

12 December 2020

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

12 December 2020

The central role of CD4(+) T cells in the antitumor immune response

1 reference

12 December 2020

Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells

1 reference

12 December 2020

Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

1 reference

12 December 2020

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

1 reference

12 December 2020

Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6

1 reference

12 December 2020

Role of cytokines in determining T-lymphocyte function

1 reference

12 December 2020

Immunological Surveillance in Neoplasia

1 reference

12 December 2020

Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes

1 reference

12 December 2020

Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization

1 reference

12 December 2020

Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8.

1 reference

12 December 2020

Reviving suppression?

1 reference

12 December 2020

Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors

1 reference

12 December 2020

T cell tolerance by clonal elimination in the thymus

1 reference

12 December 2020

Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis

1 reference

12 December 2020

Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice

1 reference

12 December 2020

The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation.

1 reference

12 December 2020

Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells

1 reference

12 December 2020

The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells

1 reference

12 December 2020

10.1007/S00281-004-0193-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1023748482

0 references

1 reference